Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
about
Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI studyIncorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.A review of minodronic acid hydrate for the treatment of osteoporosis.Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers.Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial.Milk fortified with vitamin D could reduce the prevalence of vitamin D deficiency among Japanese female college students.Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.Evaluation of crystallographic orientation of biological apatite in vertebral cortical bone in ovariectomized cynomolgus monkeys treated with minodronic acid and alendronate.Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.Minodronate for the treatment of osteoporosis.
P2860
Q34051900-1643B4F9-587B-47E2-BFD3-DF8A9696F760Q35092609-BDAC32B2-C383-412C-99FC-6BA600CEB199Q36627019-355395E6-397D-41FF-A36E-C0F799B9A9E8Q37649859-EE9E3549-90E6-411E-B608-8C125830542CQ43771659-420F9F2F-8051-4837-BD7D-DBB37FACFBF5Q45139336-52A44FBC-068E-48F5-806E-C65765FB7FD0Q48060095-62FBC681-19DE-4E11-98F3-C4E48A5C46C9Q50184850-7BFCF718-91C6-4FE7-97CF-39EFA06D9CBCQ51037431-41097D25-3E04-457A-B358-E9EC22507101Q51135820-0097EC44-E043-4D63-8870-0F88207C5997Q55077666-46D93004-BA75-4497-A720-8F73FA3AB72F
P2860
Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efficacy and safety of monthly ...... with involutional osteoporosis
@ast
Efficacy and safety of monthly ...... with involutional osteoporosis
@en
type
label
Efficacy and safety of monthly ...... with involutional osteoporosis
@ast
Efficacy and safety of monthly ...... with involutional osteoporosis
@en
prefLabel
Efficacy and safety of monthly ...... with involutional osteoporosis
@ast
Efficacy and safety of monthly ...... with involutional osteoporosis
@en
P2093
P2860
P1476
Efficacy and safety of monthly ...... with involutional osteoporosis
@en
P2093
H Mizunuma
M Fukunaga
T Matsumoto
T Nakamura
Y Nishizawa
P2860
P2888
P304
P356
10.1007/S00198-011-1782-Z
P407
P577
2011-09-20T00:00:00Z